TIP836: Exor NV (EXO): The Massive Discount Continues To Widen w/ Kyle Grieve & Shawn O’Malley

What It Covers

Kyle Grieve and Shawn O'Malley revisit their Exor NV investment thesis, examining how the Italian holding company's ~60% discount to net asset value has widened since purchase at $86/share (now $79), with Ferrari as the primary underlying asset trading at 36x earnings after falling from 57x, and assess whether the thesis remains intact.

Key Questions Answered

• •Holding Company Discount Dynamics: Buying Exor at a 60% discount to NAV effectively provides Ferrari exposure at roughly 15x earnings when Ferrari itself trades at 30x — a structural arbitrage that requires no catalyst beyond NAV convergence. Historical average discount for Exor is ~30%, meaning even partial normalization from 60% to 30% represents a standalone double before any Ferrari business compounding occurs.
• •Ferrari Valuation Reset: Ferrari's management guided 5% annual revenue growth over five years at a time when the stock priced in significantly higher rates, compressing the PE from 57x to 36x. Investors should track whether operating margins reach the guided 29.5%–30% target — already within 0.5% — as margin expansion can drive earnings-per-share growth faster than top-line revenue when pricing power remains intact.
• •Luxury Brand Scarcity as Recession Hedge: Ferrari's waitlist model creates structural demand resilience — customers called to purchase during economic downturns typically proceed to maintain standing with the brand. During COVID, Ferrari revenue declined only 8%, the sole revenue drop since IPO, while the PE multiple held mostly above 40x even during lockdowns, demonstrating the defensive quality embedded in scarcity-based luxury business models.
• •Ferrari Luce EV Assessment: The Luce, Ferrari's first fully electric vehicle priced at ~$590,000, sold out in China within one month of launch with an order book extending to end of 2027. The strategic intent is customer base expansion rather than retention — targeting tech-forward buyers in markets like Silicon Valley and China while existing customers continue purchasing traditional internal combustion models, which still represent 80% of the projected 2030 lineup.
• •Lingotto Asset Management Upside: Exor's internal investment management division, Lingotto, tripled AUM since its 2023 inception primarily through investment returns rather than capital inflows, with 40% gains in 2025 alone driven by concentrated positions including Carvana (up ~42x from $1.50 to $64) and Teva Pharmaceuticals (up 4x from $7 to $28). At $10B AUM with a standard 1% management fee plus 20% performance allocation, annual fee revenue could reach $340M+.
• •Kill Criteria Framework for Holding Companies: Establish explicit exit conditions combining a state and a date — approximately one year out — rather than holding open-endedly. For Exor specifically, red flags include capital allocation into mediocre acquisitions at full price instead of buybacks at a 60% NAV discount, or leadership disruption from the ongoing Agnelli family legal disputes that could remove CEO John Elkann, which would validate the market's skepticism about management quality.